Last year, hospitals across New Mexico became overwhelmed by respiratory syncytial virus. Now, the Food and Drug Administration has approved a new drug to combat hospitalizations and keep kids healthy.
“The younger you are, the more affected you can be from this virus,” Advertisement
Hospitals in New Mexico could not believe the cases flooding through their doors, but this year, experts hope it’s different.
“It is absolutely exciting I think for every pediatrician out there who has dealt with this seasonal RSV,” Dr. Anna Duran with the University of New Mexico Hospital said.
This new drug, Beyfortus, will not only help lift some of the stress doctors deal with, but also keep hospitalizations down. It would be given to babies that come through hospitals, and would reduce hospitalizations by 75 percent.
“This is going to be a game changer for the number of children who require hospitalization, due to RSV or respiratory syncytial virus,” Duran said.
The season for RSV starts around October and dies down around March. Newborns up to one of age or born during RSV season are eligible for this drug.
Last year, hospitals across New Mexico became overwhelmed by respiratory syncytial virus. Now, the Food and Drug Administration has approved a new drug to combat hospitalizations and keep kids healthy.
“The younger you are, the more affected you can be from this virus,”
Advertisement Hospitals in New Mexico could not believe the cases flooding through their doors, but this year, experts hope it’s different.
“It is absolutely exciting I think for every pediatrician out there who has dealt with this seasonal RSV,” Dr. Anna Duran with the University of New Mexico Hospital said.
This new drug, Beyfortus, will not only help lift some of the stress doctors deal with, but also keep hospitalizations down
Add comment